Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / DMAC - DiaMedica Therapeutics to Present at the H.C. Wainwright BioConnect Conference


DMAC - DiaMedica Therapeutics to Present at the H.C. Wainwright BioConnect Conference

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical stage biopharmaceutical company developing novel treatments for neurological and kidney diseases, today announced that it will be presenting at the H.C. Wainwright BioConnect 2021 Conference, being held virtually between January 11-14, 2021.

The recorded presentation will be available on the Investors section of the Company’s website at https://ir.diamedica.com/events-and-presentations beginning Monday, January 11 th .

About DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney diseases and neurological disorders. DiaMedica’s shares are listed on The Nasdaq Capital Market under the trading symbol “DMAC.”

For more information, please visit www.diamedica.com .

View source version on businesswire.com: https://www.businesswire.com/news/home/20210111005244/en/

Scott Kellen
Chief Financial Officer
Phone: (763) 496-5118
skellen@diamedica.com

Stock Information

Company Name: DiaMedica Therapeutics Inc.
Stock Symbol: DMAC
Market: NASDAQ
Website: diamedica.com

Menu

DMAC DMAC Quote DMAC Short DMAC News DMAC Articles DMAC Message Board
Get DMAC Alerts

News, Short Squeeze, Breakout and More Instantly...